Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 4.3 EUR -6.72% Market Closed
Market Cap: 120.4m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Hyloris Pharmaceuticals SA
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyloris Pharmaceuticals SA
Net Income Peer Comparison

Comparables:
UCB
TUB

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Hyloris Pharmaceuticals SA
XBRU:HYL
Net Income
-€15.8m
CAGR 3-Years
-30%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Ucb SA
XBRU:UCB
Net Income
€343m
CAGR 3-Years
-22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Financiere de Tubize SA
XBRU:TUB
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hyloris Pharmaceuticals SA's Net Income?
Net Income
-15.8m EUR

Based on the financial report for Dec 31, 2023, Hyloris Pharmaceuticals SA's Net Income amounts to -15.8m EUR.

What is Hyloris Pharmaceuticals SA's Net Income growth rate?
Net Income CAGR 5Y
-24%

Over the last year, the Net Income growth was -46%. The average annual Net Income growth rates for Hyloris Pharmaceuticals SA have been -30% over the past three years , -24% over the past five years .

Back to Top